Clinical trial

The Effect of Weekly Semaglutide Treatment on Energy Expenditure

NCT06390501

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-04-01

PhaseNA

Study timeline

Study start (actual)2024-04-01Date precision: day

Registry last updated2026-01-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesity; Drugunresolved

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

PlaceboDRUG

Sponsors & collaborators

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06390501 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.